Article
Real-world genomic landscape of FGFR2 amplifications and fusions in solid tumors: analysis of 4,953 patients using clinical-grade NGS
2026-08-14
Abstract excerpt
Fibroblast growth factor receptor 2 (FGFR2) alterations, including amplifications and fusions, are actionable oncogenic drivers in multiple cancers, but their prevalence and genomic features are not well defined. Between October 2019 and October 2024 at Samsung Medical Center, 4,953 patients with solid tumors underwent next-generation sequencing using TruSight Oncology 500 (TSO 500) assays as part of routine clini...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7efea590-bab5-5125-9a40-a6973781307f
- DOI
- 10.1186/s12885-026-16708-6
